Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Today Tanks 874 Points Tracking Adani Stocks Selloff | ICICI Bank, SBI Fall 4% | 5 Reasons Why Indian Share Markets are Falling
Fri, 27 Jan Closing

Sensex Today Tanks 874 Points Tracking Adani Stocks Selloff | ICICI Bank, SBI Fall 4% | 5 Reasons Why Indian Share Markets are Falling

After opening the day marginally lower, Indian share markets witnessed a sharp selloff as the session progressed and ended deep in red.

Benchmark indices crashed to three-month lows today, as banking stocks witnessed a sharp selloff along with Adani group companies in the wake of a short-seller's attack on the conglomerate.

At the closing bell, the BSE Sensex stood lower by 874 points (down 1.5%).

Meanwhile, the NSE Nifty closed lower by 288 points (down 1.6%).

Tata Motors, Bajaj Auto, and ITC were among the top gainers today.

Adani Ports, Adani Enterprises, and SBI, on the other hand, were among the top losers today.

The SGX Nifty was trading at 17,689, down by 264 points, at the time of writing.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Looking to Buy Midcap Stocks?

If you're looking to buy some high-quality midcap stocks, then our co-head of research Rahul Shah has got some great recommendations.

You can get instant access to these stocks by subscribing to his popular stock research service, Midcap Value Alert.

The great news is... as part of Equitymaster's 28th anniversary celebrations... you have the chance to access this service at a huge 80% OFF

Get Full Details
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.com
---------------------------------------------------

Broader markets settled on a weak note. The BSE Midcap fell 1.3% while the BSE SmallCap index ended 1.9% lower.

Sectoral indices ended the day on a mixed note, with stocks in the power sector, banking sector, energy sector and telecom sector witnessing most of the selling. The Bank Nifty index fell around 3% intraday today.

While stocks in healthcare sector, FMCG sector and auto sector witnessed buying.

Shares of Jindal Saw hit its 52-week highs today.

If you're interested in knowing which shares to trade, read our guide on the best intraday stocks for today.

Asian share markets ended the day on positive note. The Hang Seng ended higher by 0.5% while the Shanghai Composite index gained 0.8%. The Nikkei ended flat.

US stock futures are trading on a negative note. Dow futures are trading lower by 0.1% while Nasdaq futures are trading down by 0.3%.

The rupee is trading at 81.53 against the US$.

Gold prices for the latest contract on MCX are trading lower by 0.5% at Rs 57,189 per 10 grams.

Meanwhile, silver prices for the latest contract on MCX are trading flat at Rs 68,650 per kg.

Here are five reasons why Indian share markets plunged today.

#1 Tracking sharp selloff in Adani group stocks

Following the release of a report by US-based Hindenburg Research against the Adani Group, all Adani group stocks witnessed a steep selloff.

On Friday, five Adani group stocks - Adani Enterprises, Adani Total Gas, Adani Transmission, Adani Green Energy, and Adani Ports & SEZ hit lower circuits in intraday trade.

Following the heavy beating, the impact seems visible on Adani Enterprises' FPO that has opened today. It received muted response.

#2 Banking stocks bleed

The Hindenburg report, which claimed that Adani's use of extreme leverage spells danger for creditors. This had a snowball effect on bank stocks today. PSU bank stocks were the worst hit with India's largest lender SBI losing more than 5%.

Other top losers included Bank of Baroda, PNB and ICICI Bank.

#3 FIIs slowdown

Foreign investors (FIIs) sold Indian equities worth Rs 23.9 billion (bn) in Wednesday's trading session. The total foreign outflows so far in January 2023 is now above Rs 167 bn, shows data available on NSDL.

#4 Rising crude oil prices

Led by hopes of demand recovery from China, Brent crude oil futures were trading higher for the second day in a row today and were trading around the US$ 88 a barrel mark.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Equitymaster's Premium Research:

Discover the Lucrative Opportunities in India's Emerging Business space

Read This Letter
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.com
---------------------------------------------

#5 Pre-budget jitters

Traders and investors remained cautious ahead of two big events in the coming week - Union Budget and Fed meeting outcome. Both events are coinciding on 1 February 2023.

Speaking of stock markets, research analyst Brijesh Bhatia talks about stocks under Rs 100 to add to your watchlist in his latest video.

The stock selection is purely selected based on technical indicators and not their fundamentals.

He focuses on 10 technical potential stocks from the midcap and smallcap space. He also talks about a sector to keep an eye on going forward.

Tune in to the below video for more details.

DLF to launch premium housing project

In news from the real estate sector, share price of DLF gained 1.2% today.

Realty major DLF plans to launch a luxury housing project in Gurugram next month with an estimated sales revenue of around Rs 75 bn as it seeks to tap strong demand for high-end apartments.

The company plans to develop around 1,100 apartments in this residential project.

It has achieved a 45% growth in sales bookings to Rs 65.9 bn in the April-December period and is on track to achieve its annual sales guidance of Rs 80 bn.

The company has launched apartments and independent floors at different price points, which helped achieve better sales.

For the financial year 2022-23, it has launched residential projects in Delhi, Gurugram, Panchkula and Chennai.

The company, on 25 January 2023, reported a 37% YoY rise in profits at Rs 5.2 bn for December 2022 quarter.

However, the total revenue fell to Rs 15.6 bn from Rs 16.9 bn in the same quarter last year.

At present, the real estate sector cycle looks strong.

DLF is India's largest real estate company in terms of market capitalisation. It is one of the best real estate stocks in India.

Due to volatile markets and rising interest rates, shares of DLF fell 11% last month. While over the past one year, the share price is down by 6%.

chart

Glenmark Life Sciences Q3 update

Moving on to news from pharma sector, shares of Glenmark Life Sciences were in focus today.

Indian active pharma ingredients maker Glenmark Life Sciences on Friday reported a narrow 1% YoY rise in quarterly profit. This marginal growth was due to its key generic active pharma ingredients (API) segment revenue.

The profit rose to Rs 1.1 bn (US$12.8 m) in the December 2022 quarter from Rs 1 bn a year ago.

The generic API segment, which contributes to almost 90% of the company's revenue, grew 1.8%, benefiting from a capacity expansion at the company's Dahej facility, as well as growth in its regulated markets business.

The expansion for generic API products at the facility was completed with 240 KL capacity and was operational from this quarter.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Want Low Risk Stocks with High Growth Potential?

Access Our Premium Research on Safe Stocks at 60% Off

Full Details Here
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.com
---------------------------------------------------

Growth in this segment managed to offset the 12% YoY jump in input cost and 31% YoY decline in its contract development and manufacturing organization (CDMO) business.

Glenmark Life Sciences is a leading developer and manufacturer of select high-value, non-commoditized Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas. It is a subsidiary of Glenmark Pharmaceuticals.

Dr Reddy's Laboratories launches new eye drop in the US market

Further in the news, share price of Dr Reddy's Laboratories jumped 2.9% today.

Dr Reddy's Laboratories on Friday announced the launch of Difluprednate Ophthalmic Emulsion.

This medication is used to treat swelling and pain after eye surgery. It will be available in the market in 5 ml bottles in case packs of 24.

According to IQVIA, the Durezol and generic drug had US sales of approximately US$40 m for the most recent twelve months ending in November 2022.

Sun Pharma and Dr Reddy's are competing with each other to grab the top spot. Check out Sun Pharma vs Dr Reddy's to find out which is better.

And to know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Today Tanks 874 Points Tracking Adani Stocks Selloff | ICICI Bank, SBI Fall 4% | 5 Reasons Why Indian Share Markets are Falling". Click here!